ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,983.60
      0.00%
      Dow Jones
      37,815.92
      0.00%
      Brent Oil
      85.185
      -0.83%
      Bitcoin
      58,016.49
      -4.26%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kronos Bio Inc (KRON)

      7. Kronos Bio Inc (KRON) News

      KRON

      Kronos Bio (KRON)

      Kronos Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KRON
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      04/24/20244:01PMGlobeNewswire Inc.Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:KRONKronos Bio Inc
      03/21/20247:05AMGlobeNewswire Inc.Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial ResultsNASDAQ:KRONKronos Bio Inc
      03/07/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
      03/07/20244:05PMGlobeNewswire Inc.Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash RunwayNASDAQ:KRONKronos Bio Inc
      03/05/20244:44PMGlobeNewswire Inc.Kronos Bio To Present Three Posters at AACR 2024 Annual MeetingNASDAQ:KRONKronos Bio Inc
      03/05/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
      02/27/20244:05PMGlobeNewswire Inc.Kronos Bio Announces Participation in 44th Annual Cowen Health Care ConferenceNASDAQ:KRONKronos Bio Inc
      02/23/20248:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      02/23/20248:06PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      02/23/20248:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      02/23/20248:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      01/25/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
      01/05/20246:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      01/05/20246:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      01/05/20246:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      12/18/20234:06PMGlobeNewswire Inc.Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development CandidateNASDAQ:KRONKronos Bio Inc
      12/13/20234:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      12/13/20234:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
      12/04/20238:00AMGlobeNewswire Inc.Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceNASDAQ:KRONKronos Bio Inc
      11/27/20234:05PMGlobeNewswire Inc.Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:KRONKronos Bio Inc
      11/13/20234:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
      11/13/20234:05PMGlobeNewswire Inc.Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial ResultsNASDAQ:KRONKronos Bio Inc
      11/13/20234:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRONKronos Bio Inc
      11/02/20234:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
      11/02/20234:05PMGlobeNewswire Inc.Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 StudyNASDAQ:KRONKronos Bio Inc
      11/02/202312:00PMGlobeNewswire Inc.Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual MeetingNASDAQ:KRONKronos Bio Inc
      10/27/20238:00AMGlobeNewswire Inc.Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual MeetingNASDAQ:KRONKronos Bio Inc
      10/13/202312:30PMGlobeNewswire Inc.Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTCNASDAQ:KRONKronos Bio Inc
      10/05/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
       Showing the most relevant articles for your search:NASDAQ:KRON